vTv Therapeutics Inc. - Class A (VTVT) earnings
VTVT earnings moved a median of +0.21% by the close. Quarterly and annual VTVT reports and results, each read against the price at its own news timestamp. Back to the VTVT overview →
16 measured VTVT earnings events.
Where these VTVT earnings landedvs 16 measured VTVT earnings reactions
| Middle 50% of VTVT earnings reactions | -1.30% to +4.67% |
|---|---|
| Median reaction (to close) | +0.21% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 VTVT earnings events with a measured close landed between -1.30% and +4.67%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q vTv Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.03% | +2.20% | |
| vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +2.53% | +0.49% | |
| Form 10-Q vTv Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.18% | +15.34% | |
| vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.18% | +15.34% | |
| Form 10-K vTv Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -8.69% | |
| Form 10-Q vTv Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +4.67% | |
| vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | — | +4.67% | |
| Form 10-Q vTv Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.21% | |
| vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.00% | +0.21% | |
| Form 10-Q vTv Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -6.16% | |
| Form 10-K vTv Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -0.12% | -0.48% | |
| Form 10-Q vTv Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.01% | +7.97% | |
| Form 10-Q vTv Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.15% | |
| Form 10-Q vTv Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -1.18% | |
| Form 10-K vTv Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -0.87% | -3.66% | |
| Form 10-Q vTv Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.00% | -1.67% |
Keep exploring
More VTVT: analyst actions → · SEC filings → · VTVT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIO BLAST PHARMA LTD ORDINARY (ORPN) | 180 | 0.00% | 35% |
| scPharmaceuticals Inc. (SCPH) | 180 | +0.09% | 50% |
| SOL GLOBAL INVTS CORP (SOLCF) | 179 | 0.00% | 49% |
| Heartbeam, Inc. (BEAT) | 178 | -0.55% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.